Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPSTONE-AD
NCT07152600Phase 3Not yet recruiting
- Sponsor
- Qingyuan Zhan
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection in community acquired pneumonia (CAP), sponsored by Qingyuan Zhan. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07152600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07152600.